title: Insulin resistance and bone strength: findings from the study of midlife in the United States.
abstract: Although several studies have noted increased fracture risk in individuals with type 2 diabetes mellitus (T2DM), the pathophysiologic mechanisms underlying this association are not known. We hypothesize that insulin resistance (the key pathology in T2DM) negatively influences bone remodeling and leads to reduced bone strength. Data for this study came from 717 participants in the Biomarker Project of the Midlife in the United States Study (MIDUS II). The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated from fasting morning blood glucose and insulin levels. Projected 2D (areal) bone mineral density (BMD) was measured in the lumbar spine and left hip using dual-energy X-ray absorptiometry (DXA). Femoral neck axis length and width were measured from the hip DXA scans, and combined with BMD and body weight and height to create composite indices of femoral neck strength relative to load in three different failure modes: compression, bending, and impact. We used multiple linear regressions to examine the relationship between HOMA-IR and bone strength, adjusted for age, gender, race/ethnicity, menopausal transition stage (in women), and study site. Greater HOMA-IR was associated with lower values of all three composite indices of femoral neck strength relative to load, but was not associated with BMD in the femoral neck. Every doubling of HOMA-IR was associated with a 0.34 to 0.40 SD decrement in the strength indices (p<0.001). On their own, higher levels of fasting insulin (but not of glucose) were independently associated with lower bone strength. Our study confirms that greater insulin resistance is related to lower femoral neck strength relative to load. Further, we note that hyperinsulinemia, rather than hyperglycemia, underlies this relationship. Although cross-sectional associations do not prove causality, our findings do suggest that insulin resistance and in particular, hyperinsulinemia, may negatively affect bone strength relative to load.
authors: Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
authors: Preethi
authors: P
authors: Srikanthan
authors: Carolyn J
authors: CJ
authors: Crandall
authors: Dana
authors: D
authors: Miller-Martinez
authors: Teresa E
authors: TE
authors: Seeman
authors: Gail A
authors: GA
authors: Greendale
authors: Neil
authors: N
authors: Binkley
authors: Arun S
authors: AS
authors: Karlamangla
mesh_terms: D000368:Aged; D001842:Bone and Bones / Q000503:physiopathology*; D006801:Humans; D007333:Insulin Resistance; D008875:Middle Aged; D014481:United States
keywords: BONE STRENGTH; INSULIN RESISTANCE
references: JAMA. 2011 Jun 1;305(21):2184-92
references: 21632482
references: Metabolism. 1993 Jun;42(6):735-8
references: 8510518
references: Cell. 2010 Jul 23;142(2):309-19
references: 20655471
references: J Bone Miner Res. 2009 Aug;24(8):1369-79
references: 19292617
references: J Rheumatol. 1987 May;14 Spec No:91-3
references: 3305943
references: Eur J Endocrinol. 2012 Jun;166(6):959-67
references: 22436399
references: Curr Opin Endocrinol Diabetes Obes. 2007 Dec;14(6):429-35
references: 17982347
references: J Dent Res. 2013 Jun;92(6):560-5
references: 23569161
references: J Bone Miner Res. 2011 Mar;26(3):496-502
references: 20814955
references: J Clin Endocrinol Metab. 2008 Mar;93(3):861-8
references: 18160467
references: J Clin Endocrinol Metab. 2006 Sep;91(9):3404-10
references: 16804043
references: Curr Rheumatol Rep. 2010 Jun;12(3):186-91
references: 20425518
references: J Clin Invest. 1981 Feb;67(2):328-35
references: 7462421
references: J Aging Health. 2010 Apr;22(3):307-31
references: 20103686
references: Osteoporos Int. 2009 Oct;20(10):1767-74
references: 19238304
references: Climacteric. 2011 Oct;14(5):529-34
references: 21395451
references: Osteoporos Int. 2005 Dec;16(12):1713-20
references: 15940395
references: Osteoporos Int. 2004 Jan;15(1):62-70
references: 14605798
references: J Clin Endocrinol Metab. 2010 Nov;95(11):5045-55
references: 20719835
references: Cell. 2007 Aug 10;130(3):456-69
references: 17693256
references: J Bone Miner Res. 2007 Nov;22(11):1781-90
references: 17638578
references: JAMA. 2009 Oct 14;302(14):1573-9
references: 19826027
references: Bone Marrow Transplant. 2009 Jun;43(12):953-7
references: 19363530
references: Am J Med. 2011 Nov;124(11):1043-50
references: 22017783
references: J Clin Endocrinol Metab. 2008 Dec;93(12):4804-9
references: 18796521
references: Bone. 2008 Apr;42(4):606-15
references: 18280232
references: Osteoporos Int. 2000;11(8):714-20
references: 11095176
references: Osteoporos Int. 2002 Sep;13(9):688-700
references: 12195532
references: J Aging Health. 2010 Dec;22(8):1059-80
references: 20876364
references: Nutr Res. 2013 Jan;33(1):67-75
references: 23351412
references: Bone. 2012 Jul;51(1):107-13
references: 22543227
references: Can Med Assoc J. 1967 Jan 21;96(3):132-9
references: 6017698
references: J Clin Endocrinol Metab. 2006 Sep;91(9):3355-63
references: 16735485
references: Arch Intern Med. 2005 Jul 25;165(14):1612-7
references: 16043679
references: Curr Opin Endocrinol Diabetes Obes. 2009 Dec;16(6):435-45
references: 19779334
references: World J Orthop. 2012 Nov 18;3(11):190-8
references: 23330074
references: J Bone Miner Res. 2004 Jul;19(7):1084-91
references: 15176990
references: Osteoporos Int. 1999;9 Suppl 2:S9-S16
references: 10525720
references: J Clin Endocrinol Metab. 2012 Jan;97(1):190-7
references: 22072739
references: J Nutr Biochem. 2013 Feb;24(2):412-8
references: 22560354
references: J Bone Miner Res. 2009 Mar;24(3):475-83
references: 19049327
references: Diabetes Care. 2012 Apr;35(4):738-40
references: 22323417
references: Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S3-8
references: 20489418
references: Osteoporos Int. 2006;17(4):593-9
references: 16447009
references: Clin Endocrinol (Oxf). 2004 Aug;61(2):244-9
references: 15272921
references: J Bone Miner Metab. 2009;27(5):613-9
references: 19466592
references: Diabetes Metab Res Rev. 2010 Nov;26(8):622-30
references: 20938995
references: J Biomech Eng. 1991 Nov;113(4):366-74
references: 1762432
references: Diabetes Metab Res Rev. 2009 Nov;25(8):768-72
references: 19877133
references: J Clin Endocrinol Metab. 2012 Oct;97(10):3593-602
references: 22865903
references: Maturitas. 1981 Dec;3(3-4):249-64
references: 7334935
references: J Bone Miner Res. 2010 Feb;25(2):292-7
references: 19821769
references: Osteoporos Int. 2007 Apr;18(4):427-44
references: 17068657
references: J Clin Densitom. 2012 Apr-Jun;15(2):186-90
references: 22321655
references: Diabetes Care. 2004 Jun;27(6):1487-95
references: 15161807
references: Calcif Tissue Int. 2010 Oct;87(4):324-32
references: 20814670
references: Osteoporos Int. 2007 Oct;18(10):1337-44
references: 17492393
references: Osteoporos Int. 2011 May;22(5):1367-76
references: 20658126
references: J Diabetes. 2009 Dec;1(4):246-54
references: 20923525
references: J Bone Miner Res. 2005 Dec;20(12):2090-6
references: 16294262
references: J Bone Miner Res. 2010 Feb;25(2):285-91
references: 19594301
references: Osteoporos Int. 2010 Feb;21(2):195-214
references: 19760059
references: Cell. 2010 Jul 23;142(2):296-308
references: 20655470